According to the SEC Form 4 filings, Espinoza Octavio, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $13,031,587 | 4 | 100 |
| 2026-08-12 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 31,641 0.1572% | $292.06 | $9.24M | +0.59% | |
| 2026-03-11 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 3,057 0.0156% | $225.00 | $687,825 | +28.64% | |
| 2026-03-04 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 13,423 0.0672% | $205.83 | $2.76M | +36.05% | |
| 2025-12-12 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 1,804 0.0091% | $188.31 | $339,711 | +22.8% | |
| 2025-05-09 | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 1,500 0.0077% | $104.06 | $156,090 | +78.49% | ||
| 2025-03-04 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 5,000 0.0262% | $115.03 | $575,149 | +43.51% | |
| 2024-12-23 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 2,104 0.0113% | $116.37 | $244,850 | +4.4% | |
| 2024-09-20 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 1,275 0.0071% | $103.94 | $132,518 | +10.66% | |
| 2024-05-17 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 5,156 0.0289% | $86.66 | $446,844 | +23.39% | |
| 2024-05-16 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 2,264 0.0126% | $86.00 | $194,712 | +24.84% | |
| 2024-05-15 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 5,873 0.0328% | $86.01 | $505,148 | +23.74% | |
| 2024-02-28 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 140 0.0008% | $88.46 | $12,384 | +21.85% | |
| 2022-11-09 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Financial Officer | 1,696 0.0101% | $75.64 | $128,283 | -6.99% |